跳至主要内容
临床试验/NCT02728440
NCT02728440已完成不适用

Lipid Profile and Oxidative Stress Parameters of Patients With Idiopathic Hypogonadotropic Hypogonadism and the Change of These Parameters With Gonadotropin Replacement Therapy

Gulhane School of Medicine0 个研究点目标入组 30 人开始时间: 2010年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
30
主要终点
oxidative stress after hCG and HMG treatment

研究概览

简要总结

Effects of gonadotrophin replacement therapy Lipid Profile and Oxidative Stress Parameters of Patients with Idiopathic Hypogonadotropic Hypogonadism

详细描述

30 male patients diagnosed with IHH and a control group of 20 healthy cases with similar age and BMI were included in the study. The levels of advanced oxidation protein products (AOPP), thiol, malondialdehyde (MDA), nitric oxide (NO) and 8-hydroxydeoxyguanosine (8-OHdG) and the levels of triglyceride (TG), total cholesterol (TC), high density lipoprotein (HDL-K), low density lipoprotein (LDL-K), Apolipoprotein A1 (ApoA1) and Apolipoprotein B100 (ApoB100) were measured before and after gonadotrophin therapy.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
22 Years 至 35 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Serum testosterone concentration < 300ng/dL Absence of a pituitary or hypothalamic mass lesions, Presence of gonadotropin response to GnRH, -

排除标准

  • diabetes mellitus, arterial hypertension other hormone deficiencies

研究组 & 干预措施

Hypogonadotropic hypogonadism patients

30 patients with idiopathic hypogonadotrophic hypogonadism

干预措施: human chorionic gonadotropin, human menopausal gonadotropin (Drug)

结局指标

主要结局

oxidative stress after hCG and HMG treatment

时间窗: 2010-2012

HDL levels after hCG treatment

时间窗: 2010-2012

total cholesterole levels after hCG treatment

时间窗: 2010-2012

次要结局

未报告次要终点

研究者

发起方
Gulhane School of Medicine
申办方类型
Other
责任方
Principal Investigator
主要研究者

Aydogan Aydogdu

MD

Gulhane School of Medicine

相似试验

Effects of Gonadotropin Replacement Therapy on... | 临床试验